Literature DB >> 25391610

Intravenous immune globulins (IVIg) treatment for organizing pneumonia in a selective IgG immune deficiency state.

Itai Gueta1, Yehuda Shoenfeld, Hedi Orbach.   

Abstract

We describe herein a 61-year-old woman who presented with fever, night sweats and cough. The diagnosis of pneumonia was established, but with symptom recurrence following antibiotic therapy, further diagnostics were performed. Biopsy via bronchoscopy revealed cryptogenic organizing pneumonia, and later on follow-up, a selective IgG immune deficiency was also diagnosed. Initial treatment of high-dose glucocorticoid therapy induced remission, but with dose reduction recurrence was observed. Intravenous immune globulin treatment was initiated and induced a successful clinical and radiological remission. Few cases of cryptogenic organizing pneumonia and hypogammaglobulinemia have been reported. To our knowledge, this is the fourth case described of cryptogenic organizing pneumonia with a hypogammaglobulinemia state and the first reported case of a selective immune deficiency state treated successfully with intravenous immune globulins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391610     DOI: 10.1007/s12026-014-8571-7

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  29 in total

1.  Dyspnea and pulmonary infiltrates in a 53-year-old woman with common variable immunodeficiency.

Authors:  D A Dibbern; H N Claman; S C Dreskin
Journal:  Ann Allergy Asthma Immunol       Date:  2001-07       Impact factor: 6.347

2.  Organizing pneumonia in a patient with newly diagnosed acquired immunodeficiency syndrome.

Authors:  So Yeon Lim; Yon Ju Ryu; Jin Hwa Lee; Eun-Mi Chun; Jung Hyun Chang; Sung Shine Shim
Journal:  Intern Med       Date:  2010-11-01       Impact factor: 1.271

3.  Bronchoalveolar lavage, histological and immunohistochemical features in cryptogenic organizing pneumonia.

Authors:  V Poletti; G Castrilli; M Romagna; A Colasante; F B Aiello; G Baruzzi; P Musiani
Journal:  Monaldi Arch Chest Dis       Date:  1996-08

4.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

5.  Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings.

Authors:  H D Tazelaar; R W Viggiano; J Pickersgill; T V Colby
Journal:  Am Rev Respir Dis       Date:  1990-03

Review 6.  Bronchiolitis obliterans organizing pneumonia associated with polymyalgia rheumatica.

Authors:  C Stey; K Truninger; D Marti; P Vogt; T C Medici
Journal:  Eur Respir J       Date:  1999-04       Impact factor: 16.671

Review 7.  Bronchiolitis obliterans organizing pneumonia: definition and clinical features.

Authors:  G R Epler
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

8.  The histological diagnosis of clinically documented cases of cryptogenic organizing pneumonia: diagnostic features in transbronchial biopsies.

Authors:  R Dina; M N Sheppard
Journal:  Histopathology       Date:  1993-12       Impact factor: 5.087

9.  Rapidly progressive bronchiolitis obliterans with organizing pneumonia.

Authors:  A J Cohen; T E King; G P Downey
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

10.  Glucocorticoids inhibit IL-1beta-induced GM-CSF expression at multiple levels: roles for the ERK pathway and repression by MKP-1.

Authors:  Robert Newton; Elizabeth M King; Wei Gong; Christopher F Rider; Karl J Staples; Neil S Holden; Martin W Bergmann
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

View more
  3 in total

1.  Introduction to the special issue on the 9th International Congress on Autoimmunity.

Authors:  Eric Rosenthal; Mathilde Versini; Pierre-Yves Jeandel; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  SARS-CoV-2 Inflammatory Syndrome. Clinical Features and Rationale for Immunological Treatment.

Authors:  Marcella Prete; Elvira Favoino; Giacomo Catacchio; Vito Racanelli; Federico Perosa
Journal:  Int J Mol Sci       Date:  2020-05-10       Impact factor: 5.923

3.  The youngest surviving COVID-19 patient: A case report.

Authors:  Farnaz Kalani-Moghaddam; Nasim Pouralizadeh; Guitti Pourdowlat; Shima Sarfarazi-Moghaddam; Mohammad Hadi Gharib; Manizhe Pakdel
Journal:  Int J Surg Case Rep       Date:  2022-04-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.